Pulmonx Corporation (LUNG)
NASDAQ·Healthcare·Medical - Devices
$1.24
-3.52%
Mkt Cap $54.06M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 4, 2026 | $21.73M | $22.60M | +4.00% | -$0.39 | -$0.25 | +35.90% | — | — |
| Q4 2025 Nov 12, 2025 | $21.73M | $21.50M | -1.04% | -$0.40 | -$0.34 | +15.00% | — | — |
| Q3 2025 Jul 30, 2025 | $23.39M | $23.86M | +1.99% | -$0.40 | -$0.38 | +5.00% | — | — |
| Q2 2025 Apr 30, 2025 | $22.03M | $22.54M | +2.29% | -$0.37 | -$0.36 | +2.70% | — | — |
| Q1 2025 Feb 19, 2025 | $22.29M | $23.77M | +6.61% | -$0.45 | -$0.33 | +26.67% | — | — |
| Q4 2024 Oct 30, 2024 | $22.29M | $20.39M | -8.55% | -$0.43 | -$0.36 | +16.28% | — | — |
| Q3 2024 Jul 31, 2024 | $20.13M | $20.78M | +3.24% | -$0.41 | -$0.39 | +4.88% | — | — |
| Q2 2024 May 1, 2024 | $17.89M | $18.85M | +5.39% | -$0.43 | -$0.36 | +16.28% | — | — |
| Q1 2024 Feb 21, 2024 | $18.27M | $19.28M | +5.52% | -$0.39 | -$0.36 | +7.69% | — | — |
| Q4 2023 Oct 30, 2023 | $16.39M | $17.67M | +7.80% | -$0.45 | -$0.39 | +13.33% | — | — |
| Q3 2023 Aug 2, 2023 | $15.86M | $17.19M | +8.41% | -$0.43 | -$0.43 | +0.00% | — | — |
| Q2 2023 May 2, 2023 | $13.49M | $14.54M | +7.75% | -$0.43 | -$0.42 | +2.33% | — | — |
| Q1 2023 Feb 22, 2023 | $13.98M | $15.43M | +10.35% | -$0.41 | -$0.38 | +7.32% | — | — |
| Q4 2022 Nov 3, 2022 | $14.93M | $13.50M | -9.59% | -$0.40 | -$0.38 | +5.00% | — | — |
| Q3 2022 Aug 2, 2022 | $13.77M | $13.95M | +1.31% | -$0.41 | -$0.40 | +2.44% | — | — |
| Q2 2022 May 3, 2022 | $9.26M | $10.79M | +16.44% | -$0.37 | -$0.43 | -16.22% | — | — |
| Q1 2022 Feb 23, 2022 | $14.24M | $13.71M | -3.75% | -$0.35 | -$0.35 | +0.00% | — | — |
| Q4 2021 Nov 2, 2021 | $13.18M | $13.26M | +0.61% | -$0.37 | -$0.28 | +24.32% | — | — |
| Q3 2021 Aug 3, 2021 | $12.20M | $12.20M | +0.00% | -$0.38 | -$0.34 | +10.53% | — | — |
| Q2 2021 May 4, 2021 | $10.22M | $9.24M | -9.52% | -$0.39 | -$0.34 | +12.82% | — | — |